Verition Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,700
Closed -$252K 3706
2024
Q4
$252K Sell
27,700
-3,400
-11% -$32.8K ﹤0.01% 2860
2024
Q3
$285K Hold
31,100
﹤0.01% 2671
2024
Q2
$304K Buy
+31,100
New +$379K ﹤0.01% 2337
2022
Q1
Sell
-2,300
Closed -$211K 3025
2021
Q4
$211K Buy
+2,300
New +$275K ﹤0.01% 2226
2019
Q4
Sell
-7,600
Closed -$515K 1359
2019
Q3
$515K Buy
+7,600
New +$500K 0.01% 614

Other funds holding TDOC

Verition Fund Management's TDOC Position: Q1 2026 in Review

Verition Fund Management reduced its Teladoc Health (TDOC) stake by 90% in Q1 2026, selling an estimated $1.73M and leaving 35,379 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Verition Fund Management first reported a position in TDOC in Q2 2019 and has held it in 19 quarters since. The position peaked at $2.53M in Q3 2019. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Verition Fund Management held 35,379 shares of Teladoc Health worth $193K as of Q1 2026.
  • Verition Fund Management sold 308,537 Teladoc Health shares in Q1 2026, an estimated $1.73M.
  • Teladoc Health made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1956 holding.
  • Verition Fund Management first reported a position in Teladoc Health in Q2 2019 and has held it in 19 quarters since.
  • Verition Fund Management's Teladoc Health position peaked at $2.53M in Q3 2019.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.